In a case of pediatric hypoglycemia, which of the following is a contraindicated treatment?

In the context of pediatric hypoglycemia, the administration of insulin is contraindicated because it is a drug used to lower blood glucose levels. In cases of hypoglycemia, which is characterized by abnormally low blood sugar, the priority is to elevate blood glucose to a safe level. Administering insulin would exacerbate the hypoglycemic condition, making it dangerous for the child.

On the other hand, intravenous administration of dextrose, oral administration of sugar, and intramuscular glucagon are all appropriate treatments for hypoglycemia. Dextrose can rapidly elevate glucose levels, while glucagon serves as a hormone that stimulates the liver to release stored glucose into the bloodstream. Oral sugar can also be effective, especially in conscious children who can safely swallow.

Hence, insulin should never be administered in a hypoglycemic scenario, as it contradicts the immediate need to elevate blood glucose levels. This aligns with established guidelines in emergency medicine for managing hypoglycemia in a pediatric population.